This announcement is made by and on behalf of the Board of Directors of Dea Diagnostics Technology Group Co., Ltd. to ensure the truthfulness, accuracy, and completeness of the information disclosed, and to avoid false or misleading statements or material omissions.
Dea Diagnostics Technology Group Co., Ltd. (hereinafter referred to as the "Company") was recently notified by its controlling shareholder, Mr. Chen Haibin, that he has pledged and released a portion of his shares in the Company. The relevant pledge and release procedures have been completed. The specific details are as follows:
I. Details of the Shareholder's Latest Share Pledge
| Shareholder Name | Is it a Controlling Shareholder or First Largest Shareholder and their Concerted Parties | Number of Shares Pledged (10,000 shares) | Proportion of Shares Held | Proportion of Total Share Capital | Is it Restricted Stock | Is it a Supplementary Pledge | Pledge Start Date | Pledge End Date | Pledgee | Pledge Purpose |
|---|---|---|---|---|---|---|---|---|---|---|
| Chen Haibin | Yes | 1,736 | 10.56% | 2.78% | No | No | 2026/6/17 | 2027/6/16 | China Merchants Securities Co., Ltd. | Repayment of pledged loan |
| Total | / | 1,736 | 10.56% | 2.78% | / | / | / | / | / | / |
II. Details of the Shareholder's Latest Share Release